Magstim Logo

FDA Clears Magstim Transcranial Magnetic Stimulation System Horizon 3.0 with StimGuide Pro

Magstim has been awarded FDA clearance for the Horizon 3.0 with StimGuide Pro. This provides physicians, nurse practitioners, clinicians, and researchers with the most advanced transcranial magnetic stimulation technology (TMS) available to treat patients diagnosed with depressive or obsessive-compulsive conditions.

By |2024-02-02T00:01:54+00:00February 1st, 2024|Company News, TMS Therapy|0 Comments

NEW MAGSTIM ANALYTICS SOFTWARE OFFERS POWERFUL TMS DATA FOR PRACTICES, TREATERS AND DEVICE REPORTING

HIPAA Compliant TMS software provides new level of data designed [...]

By |2022-04-28T15:39:00+00:00April 28th, 2022|Company News, TMS Therapy|0 Comments

GROUNDBREAKING STUDY: After TMS treatment, 65.3% of Veterans with co-morbid PTSD and MDD demonstrated clinically meaningful reduction

In the largest study of its kind to date, medical [...]

By |2022-01-28T15:07:34+00:00January 28th, 2022|Mental Health, Neuromodulation, TMS Therapy|0 Comments

Magstim Awarded FDA (510K) Clearance for Advanced Transcranial Magnetic Stimulation (TMS) Platform Horizon 3.0

New Class of Navigated TMS Delivers Customized, Repeatable Treatments Improving [...]

By |2022-01-28T14:30:44+00:00October 28th, 2021|Company News, TMS Therapy|0 Comments

Autism Biomarkers and Research using TMS and HD-EEG – Available Now

If you missed out on our Autism Biomarkers and Research [...]